ILB Eric Kendricks

[ceerrece]

Maybe he is short, but he can play... regarding Mckinney, i heard that he is more of a two down LB, don't ask me why, that's what I heard. Kendricks looks like a safe bet at 27 to me, what about Paul Dawson from TCU?

 

[Pessimist_cowboy]

anyone have a list of players we've visited with so far ? have we visited with Kendricks ?

 

[RS12]

Eric Kendricks | Linebacker
Team: UCLA Bruins
Age / DOB: (23) / 2/29/1992
Ht / Wt: 6'0' / 228

LATEST NEWS
RECENT NEWS
UCLA LB Eric Kendricks, like brother Mychal (Philadelphia Eagles), "has that rare read-and-react instinct necessary to be a great inside linebacker," notes NFLDraftScout.com's Frank Cooney.
"We're the same blood," Eric Kendricks said at the combine when asked about Mychal. "We bring a lot of the same characteristics to the game. We can do a lot of things that a lot of people can't do. Flexibility, speed, collision at point of attack. Those are things we both bring to the table." Rotoworld ranks Kendricks as a top-10 talent and sees him as a surefire first-round talent. "Let's just agree that we can't coach genetics, measure a heart or teach instincts -- which are the basics that make Kendricks a wildly productive football player," Cooney wrote. "In the right defense, he can continue to mess with offenses for many more years." Kendricks is a three-down LB who is skilled in coverage. Mar 22 - 8:28 PM
Source: CBS Sports

 

[bodi]

McKinney is not even a 4-3 LB. If Cowboys have interest in him, its for the DE spot.

And you know how ?

well then Draft a DE - P Smith

 

[Doc50]

i just found that study to be compelling because it outlines the expression mechanics. I know enough about polypeptide chains that inserting individual aminos can change the stability of the whole. Not that different from classic load mechanics or alloy metallurgy at the end of the day.

Right. We've been vectoring nucleus acids into human cellular DNA for a few years now, starting with the first approved cancer use in 2003, and the first single-gene genetic disorder correction 2 years ago.

So back to our hypothetical LB with inherited obstacles -- we may be able to fix those, as well as primary targets such as haemophilia, sickle cell disease, cystic fibrosis, and multiple myeloma. While genetically engineered athletes may seem a bit far-fetched, the future of this gladiator sport may actually evolve into robotics.

 

[DFWJC]

FWIW...and I know they are just opinions, but in their latest mocks none of these guys had Kendricks in the first round:

Kiper-ESPN
McShay-ESPN
Brooks--NFL
Jeremiah-NFL
Casserly--NFL
Baldinger--NFL
Davis__NFL

Those were the first seven that I glanced at. I'm sure somewhere else, he makes it in the 1st. But nobody on ESPN or NFLnw has him in the first right now.

 

[FuzzyLumpkins]

Right. We've been vectoring nucleus acids into human cellular DNA for a few years now, starting with the first approved cancer use in 2003, and the first single-gene genetic disorder correction 2 years ago.

So back to our hypothetical LB with inherited obstacles -- we may be able to fix those, as well as primary targets such as haemophilia, sickle cell disease, cystic fibrosis, and multiple myeloma. While genetically engineered athletes may seem a bit far-fetched, the future of this gladiator sport may actually evolve into robotics.

It seems like it is going to be difficult to replace units in a lattice ex post facto. The ethics invovled in genetically modifying embryo's to say a TT pair is going to be huge too.

i have been tried to get involved in the neural interfacing prosthetics. I am EE and really really really want to know how they parse and encode neural stimuli from the motor cortex.

 

[Doc50]

It seems like it is going to be difficult to replace units in a lattice ex post facto. The ethics invovled in genetically modifying embryo's to say a TT pair is going to be huge too.

i have been tried to get involved in the neural interfacing prosthetics. I am EE and really really really want to know how they parse and encode neural stimuli from the motor cortex.

Good question, Fuzz.

I don't know where the leading research is centered, but Cal Tech, Stanford, and MIT have all been involved at various levels. The pharmaceutical company that developed the first human approved genetic modification therapy is uniQure, based in Amsterdam. It's mechanism is adenovirus vectoring of an intact gene into defective cells, and it works without directly altering DNA, and therefore without mutations.
The drug (Glybera) was approved in Europe in late 2012. It treats a rare disorder of lipid metabolism and costs $1.6 million per patient.

In our hypothetical LB with genetically weak connective tissue, altering or changing the genetic data would be much more complex than adding missing data.

The good news is that anyone playing football with one of these genetic outliers or a more common disorder like Ehlers-Danlos will be outed by jr high - the injury trends will already be evident, and the player won't make it to high school, let alone college.

Now, injuries from adrenergics or anabolic steroid use is another story, which will likely tear an athlete down after building him up.

If the reported leniency exists at UCLA and others, a team may certainly get less than they bargained for.

 

[Pessimist_cowboy]

Matt Eberflus flew out and watched his pro day and apparently loves the kid. Came away very impressed. If Gurley and all the DL are gone I think this is the pick.

 

[Western]

Dallas LB coach Eberflus personally visited with Kendricks at UCLA pro day, March 10th.
2014 Butkus award winner, 2014 Lott IMPACT award winner, led the country in solo tackles in 2014, & the 2013 team co-captain for the Bruins.
Has the versatility to play any of the 3 LB positions & is a day 1 'plug and play' starter at LB. Can play all the 3 downs on defense.

Due diligence and contingency plans:
Absent a fair trade for value at 27, if the players Dallas are targeting at 27 (let's say a DE, a DT or a CB, or even a RB) are for some unforeseen reason not available at 27, then the choice is between Kendricks (probably the top-rated LB in the draft, excluding the LB edge rushers) and a lesser talented DE, DT, CB or RB, go with the best player available on your board that fulfills a strategic need (given health issues for Lee, uncertainty with McClain's performance for a full year, and the natural attrition of the LB position even with the recent LB free-agent acquisitions).

Take Kendricks.